Increased risk of hepatocellular carcinoma in viral hepatitis associated end-stage liver disease (ESLD).

被引：0
|
作者：
Perez, RG [1 ]
Zein, NN [1 ]
Steers, JL [1 ]
Wiesner, RH [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,DEPT GASTROENTEROL & LIVER TRANSPLANTAT,ROCHESTER,MN 55905
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [21] Osteoporosis in patients with end-stage liver disease (ESLD) before and after transplantation.
    Castro, MR
    Khovidhunkit, W
    Rothstein, K
    Rucinski, B
    Epstein, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : T543 - T543
  • [22] Alpha-1 Antitrypsin Deficiency and the Risk of Hepatocellular Carcinoma in Patients With End-Stage Liver Disease
    Antoury, Clara
    Lopez, Rocio
    Zein, Nizar
    Stoller, James
    Alkhouri, Naim
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S138 - S138
  • [23] Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death
    McMahon, Brian J.
    Bruden, Dana
    Townshend-Bulson, Lisa
    Simons, Brenna
    Spradling, Phillip
    Livingston, Stephen
    Gove, James
    Hewitt, Annette
    Plotnik, Julia
    Homan, Chriss
    Espera, Hannah
    Negus, Susan
    Snowball, Mary
    Barbour, Youssef
    Bruce, Michael
    Gounder, Prabhu
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (03) : 431 - +
  • [24] IS OBESITY ASSOCIATED WITH AN INCREASED RISK OF MORBIDITY AND MORTALITY IN PATIENTS WITH END-STAGE LIVER DISEASE REFERRED FOR LIVER TRANSPLANTATION?
    DiTeodoro, L.
    McNeil, R.
    Dickson, R.
    Pungpapong, S.
    Aranda-Michel, J.
    Keaveny, A.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S82 - S82
  • [25] DIABETIC METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IS ASSOCIATED WITH INCREASED RISK OF HEPATOCELLULAR CARCINOMA AND MORTALITY IN CHRONIC VIRAL HEPATITIS PATIENTS
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong-Gyu
    Ahn, Sang Hoon
    HEPATOLOGY, 2022, 76 : S244 - S245
  • [26] Clinical Factors Associated with Hepatocellular Iron Deposition in End-stage Liver Disease
    Fierro-Fine, Amelia
    Guerin, Leana
    Hicsasmaz, Hasan
    Brown, Kyle E.
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2020, 8 (03) : 231 - 239
  • [27] Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong Gyu
    Ahn, Sang Hoon
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (01) : 97 - 107
  • [28] Characteristics of Nutritional Intake in End-Stage Liver Disease Secondary to Viral Hepatitis, NASH, and Alcoholic Liver Disease
    Hefner, Anna Marie
    Connelly, Cynthia D.
    James, Kathy S.
    Hill, Catherine
    Reshamwala, Preeti
    Hassanein, Tarek
    HEPATOLOGY, 2014, 60 : 336A - 336A
  • [29] Donation after cardiac death liver transplantation is associated with increased risk of end-stage renal disease
    Ruebner, Rebecca L.
    Reese, Peter P.
    Abt, Peter L.
    TRANSPLANT INTERNATIONAL, 2014, 27 (12) : 1263 - 1271
  • [30] COGNITIVE CHANGES IN END-STAGE LIVER DISEASE (ESLD) PRE- AND POST-LIVER TRANSPLANTATION
    Sakamoto, Maiko
    Perry, William
    Hilsabeck, Robin C.
    Carlson, Meghan
    Barakat, Fatma
    Hassanein, Tarek
    HEPATOLOGY, 2010, 52 (04) : 1242A - 1242A
12345